# US 2024/0199601 A1 · Quinone compound and pharmaceutical use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0199601 A1
- Document ID: US20240199601A1
- Status: Published application
- Kind: A1
- Application number: 18/285,282
- Filed: 2022-03-28
- Published: 2024-06-20
- Earliest claimed: 2021-04-02
- Assignees: Nanjing Shupeng Life Science Co., Ltd.
- Applicants: Nanjing Shupeng Life Science Co., Ltd.
- Inventors: Chuanjun WEN; Junyi ZOU; Fenyong SUN
- Web page: https://patentgrep.com/patent/US20240199601A1

## CPC

- C07D 471/04: Ortho-condensed systems
- A61K 31/4745: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines (yohimbine derivatives, vinblastine A61K31/475; ergoline derivatives A61K31/48)
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention discloses a quinone compound and pharmaceutical use thereof. The quinone compound has a chemical structure of a general formula (I). The quinone compound has a phamaceutical value and a unique analgesic effect, inhibits inflammation and inhibits invasion and growth of tumor cells. The quinone compound can be used for preparing analgesic drugs, anti-tumor drugs, anti-inflammatory drugs, drugs for treating autoimmune diseases and the like.

## Claims

### Claim 1

A compound of a formula (I) or a pharmaceutically acceptable salt, ester, stereoisomer, solvent compound or prodrug thereof,
wherein
R1 is selected from —OH, —OR, —OC(O)R, —NH2, —NHR, —SH or —SR;
R2 is selected from H, C1-C3 alkyl, NH2, NHR or —COOH;
R3 is selected from H, C1-C3 alkyl, OH, NH2, NHR, —COOH or SH;
R4 is selected from H, C1-C3 alkyl or C6-C10 aryl;
R5 is selected from H, C1-C3 alkyl, OH, NH2, NHR, —COOH or SH;
R6 is selected from H, C1-C3 alkyl, OH, NH2, NHR, —COOH or SH;
R is C1-C6 alkyl; and preferably, the R is C1-C3 alkyl.

### Claim 2 (depends on 1)

The compound of formula (I) or a pharmaceutically acceptable salt, ester, stereoisomer, solvent compound or prodrug thereof of claim 1,
wherein R2, R4, R5, and R6 are each H;
R3 is —COOH; and
R1 is selected from —OH, —OR, —OC(O)R, —NH2, —NHR, —SH or —SR; R is C1-C6 alkyl; and preferably, the R is C1-C3 alkyl.

### Claim 3

Compounds or pharmaceutically acceptable salts, esters, stereoisomers, solvent compounds or prodrugs thereof shown as follows:

### Claim 4

A method for preparing the compound of a formula (II):

### Claim 5 (depends on 1)

A pharmaceutical composition, comprising the compound of formula (I) or pharmaceutically acceptable salts, esters, stereoisomers, solvent compounds or prodrugs thereof of claim 1, and a pharmaceutically acceptable carrier.

### Claim 6 (depends on 1)

An AMPK agonist comprising the compound or a pharmaceutically acceptable salt, ester, stereoisomer, solvent compound or prodrug thereof according to agonist claim 1.

### Claim 7 (depends on 1)

An inhibitor of a Cox-2 enzyme comprising the compound or a pharmaceutically acceptable salt, ester, stereoisomer, solvent compound or prodrug thereof according to claim 1.

### Claim 8 (depends on 1)

An analgesic drug comprising the compound or a pharmaceutically acceptable salt, ester, stereoisomer, solvent compound or prodrug thereof according to claim 1.

### Claim 9 (depends on 1)

A drug for prevention and treatment of inflammatory diseases comprising the compound or a pharmaceutically acceptable salt, ester, stereoisomer, solvent compound or prodrug thereof according to claim 1.

### Claim 10 (depends on 1)

A medicament comprising the compound or a pharmaceutically acceptable salt, ester, stereoisomer, solvent compound or prodrug thereof according to claim 1, wherein the medicament is selected from the group consisting of anti-tumor drugs; chemotherapeutic treatment, chemical substances or drugs for prevention and treatment of tumors caused by cytotoxins; drugs for prevention and treatment of various liver injuries and hepatic insufficiency caused by chronic hepatitis; drugs for prevention and treatment of myocardial infarction injuries and viral myocarditis; and drugs for prevention and treatment of neurodegeneration, change diseases, epilepsy and migraine.

### Claim 11 (depends on 1)

A drug for prevention and treatment of peripheral neuropathy caused by chemotherapy comprising the compound or a pharmaceutically acceptable salt, ester, stereoisomer, solvent compound or prodrug thereof according to claim 1.

### Claim 12 (depends on 1)

A drug for prevention and treatment of depression, or a sedative or hypnotic drug comprising the compound or a pharmaceutically acceptable salt, ester, stereoisomer, solvent compound or prodrug thereof according to claim 1.
